BRIEF-Cellect Biotechnology Announces Clinical Results
January 04, 2018 at 08:11 AM EST
* CELLECT BIOTECHNOLOGY - COMPLETED TRANSPLANTATION OF FIRST GROUP OF 3 PATIENTS USING CELLECT'S APOGRAFT TECHNOLOGY IN CO'S PHASE I/II CLINICAL TRIAL
